All terms in MeSH

Label Id Description
Human Growth Hormone D019382 [Mammalian-cell derived recombinant human growth hormone. , A 191-amino acid polypeptide hormone secreted by the human adenohypophysis (PITUITARY GLAND, ANTERIOR), also known as GH or somatotropin. Synthetic growth hormone, termed somatropin, has replaced the natural form in therapeutic usage such as treatment of dwarfism in children with growth hormone deficiency. ]
Pelizaeus-Merzbacher Disease D020371 [A rare, slowly progressive disorder of myelin formation. Subtypes are referred to as classic, congenital, transitional, and adult forms of this disease. The classic form is X-chromosome linked, has its onset in infancy and is associated with a mutation of the proteolipid protein gene. Clinical manifestations include TREMOR, spasmus nutans, roving eye movements, ATAXIA, spasticity, and NYSTAGMUS, CONGENITAL. Death occurs by the third decade of life. The congenital form has similar characteristics but presents early in infancy and features rapid disease progression. Transitional and adult subtypes have a later onset and less severe symptomatology. Pathologic features include patchy areas of demyelination with preservation of perivascular islands (trigoid appearance). (From Menkes, Textbook of Child Neurology, 5th ed, p190) ]
Animals, Suckling B01.050.050.293
Nucleic Acid Synthesis Inhibitors D019384 [Compounds that inhibit cell production of DNA or RNA. ]
Oceania D044349 [The islands of the central and South Pacific, including Micronesia, Melanesia, Polynesia, and traditionally Australasia. (Random House Dictionary, 2d ed) ]
Pinus ponderosa B01.650.940.800.575.912.625.875.777.600
Pinus B01.650.940.800.575.912.625.875.777
Anti-HIV Agents D019380 [Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. ]
Phosphoric Triester Hydrolases D044345 [A class of enzymes that catalyze the hydrolysis of one of the three ester bonds in a phosphotriester-containing compound. ]
Confined Spaces D020378 [A space which has limited openings for entry and exit combined with unfavorable natural ventilation such as CAVES, refrigerators, deep tunnels, pipelines, sewers, silos, tanks, vats, mines, deep trenches or pits, vaults, manholes, chimneys, etc. ]
Receptor, Serotonin, 5-HT1D D044346 [A serotonin receptor subtype that is localized to the CAUDATE NUCLEUS; PUTAMEN; the NUCLEUS ACCUMBENS; the HIPPOCAMPUS, and the RAPHE NUCLEI. It plays a role as a terminal autoreceptor that regulates the rate of SEROTONIN release from nerve endings. This serotonin receptor subtype is closely related to and has similar drug binding properties as the 5-HT1B RECEPTOR, but is expressed at low levels. It is particularly sensitive to the agonist SUMATRIPTAN and may be involved in mediating the drug's antimigrane effect. ]
Risk Adjustment D020379 [The use of severity-of-illness measures, such as age, to estimate the risk (measurable or predictable chance of loss, injury or death) to which a patient is subject before receiving some health care intervention. This adjustment allows comparison of performance and quality across organizations, practitioners, and communities. (from JCAHO, Lexikon, 1994) ]
Sexology D044347 [This discipline concerns the study of SEXUALITY, and the application of sexual knowledge such as sexual attitudes, psychology, and SEXUAL BEHAVIOR. Scope of application generally includes educational (SEX EDUCATION), clinical (SEX COUNSELING), and other settings. ]
Dichelobacter nodosus D020376 [Genus with single species DICHELOBACTER NODOSUS. , A gram-negative, obligate anaerobe of the family Cardiobacteriaceae. It has polar fimbriae and is the causative agent of FOOT ROT and DIGITAL DERMATITIS. It is the lone species in the genus Dichelobacter. ]
Meningomyelocele C16.131.666.680.610
Receptors, Serotonin, 5-HT2 D044348 [A subclass of G-protein coupled SEROTONIN receptors that couple preferentially to the GQ-G11 G-PROTEINS resulting in increased intracellular levels of INOSITOL PHOSPHATES and free CALCIUM. ]
Self Efficacy D020377 [Cognitive mechanism based on expectations or beliefs about one's ability to perform actions necessary to produce a given effect. It is also a theoretical component of behavior change in various therapeutic treatments. (APA, Thesaurus of Psychological Index Terms, 1994) ]
Glucokinase D08.811.913.696.620.250
Photoreceptor Cells, Vertebrate A11.671.650.850.625.670
Photoreceptor Cells A11.671.650.850.625